Allison Jeynes-Ellis
Vorstandsvorsitzender bei Avillion LLP
Vermögen: 51 903 $ am 31.05.2024
Aktive Positionen von Allison Jeynes-Ellis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Avillion LLP
 Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Vorstandsvorsitzender | 01.01.2014 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.12.2012 | 01.01.2014 | |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Siolta Therapeutics, Inc.
 Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Allison Jeynes-Ellis
Ehemalige bekannte Positionen von Allison Jeynes-Ellis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AGENUS INC. | Direktor/Vorstandsmitglied | 07.11.2018 | 11.06.2024 |
| Independent Dir/Board Member | 07.11.2018 | 11.06.2024 |
Statistik
International
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AGENUS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Health Technology |
Siolta Therapeutics, Inc.
Siolta Therapeutics, Inc. BiotechnologyHealth Technology Siolta Therapeutics, Inc. engages in the development of therapeutic microbial consortia to prevent and treat inflammatory diseases. Its pipeline includes STMC-103H, STMC-144M, and STMC-123R. The company was founded by Susan V. Lynch and Nikole E. Kimes in 2016 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Allison Jeynes-Ellis
- Erfahrung